Joshua Shulman to Prospective Studies
This is a "connection" page, showing publications Joshua Shulman has written about Prospective Studies.
Connection Strength
0.478
-
Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol. 2014 Apr; 71(4):429-35.
Score: 0.079
-
Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
Score: 0.075
-
Shastry S, Carpenter J, Krotulski A, Brent J, Wax P, Aldy K, Campleman S, Culbreth R, Falise A, Hughes A, Hendrickson RG, Amaducci A, Judge B, Meaden C, Calello DP, Buchanan J, Shulman J, Levine M, Schwarz E, Manini AF. Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients. JAMA Netw Open. 2025 07 01; 8(7):e2518569.
Score: 0.043
-
Hall DA, Shulman JM, Singleton A, Bandres Ciga S, S Tosin MH, Ouyang B, Shulman L. Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study. JMIR Res Protoc. 2025 Apr 07; 14:e60587.
Score: 0.042
-
Dicker F, Lothet E, Schwarz E, Aldy K, Brent J, Wax P, Culbreth R, Campleman S, Krotulski A, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Hendrickson RG, Meaden CW, Manini AF. Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohort. Am J Emerg Med. 2025 Mar; 89:169-173.
Score: 0.041
-
Aldy K, Krotulski A, Brent J, Campleman S, Culbreth R, Logan B, Wax P, Amaducci A, Judge B, Levine M, Schwarz E, Calello DP, Meaden CW, Shulman J, Hughes A, Hendrickson R, Carpenter J, Buchanan J, Manini AF. Emergency Department Patients with Para-Fluorofentanyl Overdose. J Emerg Med. 2025 May; 72:56-69.
Score: 0.041
-
Levine M, Culbreth R, Amaducci A, Calello DP, Shulman J, Judge B, Love J, Hughes A, Schwarz ES, Carpenter J, Wax P, Aldy K, Krotulski AJ, Logan BK, Buchanan J, Brent J, Meaden CW, Hendrickson RG, Abston S, Li S, Campleman S, Manini AF. Prevalence and predictors of HIV among patients presenting to US emergency departments with opioid overdose. Drug Alcohol Depend. 2024 Nov 01; 264:112423.
Score: 0.040
-
Campleman SL, Brent J, Pizon AF, Shulman J, Wax P, Manini AF. Drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol (Phila). 2020 12; 58(12):1326-1334.
Score: 0.030
-
Buchman AS, Yu L, Wilson RS, Leurgans SE, Nag S, Shulman JM, Barnes LL, Schneider JA, Bennett DA. Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies. Neurology. 2019 04 16; 92(16):e1821-e1830.
Score: 0.028
-
Buchman AS, Leurgans SE, Yu L, Wilson RS, Lim AS, James BD, Shulman JM, Bennett DA. Incident parkinsonism in older adults without Parkinson disease. Neurology. 2016 Sep 06; 87(10):1036-44.
Score: 0.023
-
Buchman AS, Yu L, Wilson RS, Shulman JM, Boyle PA, Bennett DA. Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study. BMC Geriatr. 2014 Apr 23; 14:54.
Score: 0.020
-
Xia Z, Chibnik LB, Glanz BI, Liguori M, Shulman JM, Tran D, Khoury SJ, Chitnis T, Holyoak T, Weiner HL, Guttmann CR, De Jager PL. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. PLoS One. 2010 Nov 30; 5(11):e14169.
Score: 0.016